Chemotherapy With Cordycepin Plus Pentostatin in Treating Patients With Refractory Acute Lymphocytic or Chronic Myelogenous Leukemia
Completed · Phase 1
Conditions studied: Leukemia
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of chemotherapy consisting of cordycepin plus pentostatin in treating patients with refractory acute lymphocytic or chronic myelogenous leukemia.
Key facts
- Study ID
- NCT00003005
- Run by
- Boston Medical Center
- People needed
- 14
- Starts
- 1997-12-01
- Expected to finish
- 2001-03-01
- Last updated by the study team
- 2012-06-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Vincent T. Lombardi Cancer Research Center, Georgetown University — Washington D.C., District of Columbia, United States
- Johns Hopkins Oncology Center — Baltimore, Maryland, United States
- New England Medical Center Hospital — Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Boston Medical Center — Boston, Massachusetts, United States
- University of Massachusetts Memorial Medical Center — Worcester, Massachusetts, United States
- Washington University Barnard Cancer Center — St Louis, Missouri, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Lineberger Comprehensive Cancer Center, UNC — Chapel Hill, North Carolina, United States
- Arthur G. James Cancer Hospital - Ohio State University — Columbus, Ohio, United States
- Oregon Cancer Center at Oregon Health Sciences University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.